The initial use of the hormonal form of vitamin D, 1,25(OH)2D or calcitriol, to suppress PTH was hampered by the frequent side effects of the hypercalcemia and hyperphosphatemia resulting from the development of parathyroid resistance to calcitriol [6,7]. The gene discussed is PTH; the disease is hyperphosphatemia.